-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Downgrades Soleno Therapeutics to Peer Perform

Benzinga·04/07/2026 13:40:37
Listen to the news
Wolfe Research analyst Kalpit Patel downgrades Soleno Therapeutics (NASDAQ:SLNO) from Outperform to Peer Perform.